Tomokazu Kimura

1.4k total citations
60 papers, 533 citations indexed

About

Tomokazu Kimura is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, Tomokazu Kimura has authored 60 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 24 papers in Pulmonary and Respiratory Medicine and 8 papers in Urology. Recurrent topics in Tomokazu Kimura's work include Bladder and Urothelial Cancer Treatments (24 papers), Urinary and Genital Oncology Studies (20 papers) and Renal cell carcinoma treatment (7 papers). Tomokazu Kimura is often cited by papers focused on Bladder and Urothelial Cancer Treatments (24 papers), Urinary and Genital Oncology Studies (20 papers) and Renal cell carcinoma treatment (7 papers). Tomokazu Kimura collaborates with scholars based in Japan, United States and Egypt. Tomokazu Kimura's co-authors include Hiroyuki Nishiyama, Koji Kawai, Jun Miyazaki, Takahiro Kojima, Tsuyoshi Mitake, Tomoaki Miyagawa, Masakazu Tsutsumi, Toshiyuki Irie, Shuya Kandori and Satoru Ishikawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Tomokazu Kimura

55 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomokazu Kimura Japan 12 214 206 97 69 64 60 533
Yuan‐Tso Cheng Taiwan 13 304 1.4× 154 0.7× 172 1.8× 73 1.1× 32 0.5× 60 582
G Schmutz France 9 278 1.3× 92 0.4× 43 0.4× 37 0.5× 56 0.9× 53 535
Katrine Hansen United States 14 271 1.3× 126 0.6× 52 0.5× 64 0.9× 27 0.4× 37 591
Selda Seçkın Türkiye 17 343 1.6× 277 1.3× 140 1.4× 88 1.3× 14 0.2× 58 742
Jacki Abrams United States 16 243 1.1× 161 0.8× 136 1.4× 25 0.4× 81 1.3× 27 771
Mutahir A. Tunio Saudi Arabia 13 413 1.9× 217 1.1× 216 2.2× 63 0.9× 42 0.7× 87 709
X. Tillou France 17 346 1.6× 264 1.3× 209 2.2× 27 0.4× 34 0.5× 72 861
J. NEWMAN United Kingdom 11 279 1.3× 97 0.5× 140 1.4× 72 1.0× 166 2.6× 28 667
Ó. Rodríguez Faba Spain 15 681 3.2× 266 1.3× 166 1.7× 207 3.0× 36 0.6× 94 1.1k
Seema Kaushal India 13 201 0.9× 81 0.4× 96 1.0× 30 0.4× 9 0.1× 86 483

Countries citing papers authored by Tomokazu Kimura

Since Specialization
Citations

This map shows the geographic impact of Tomokazu Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomokazu Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomokazu Kimura more than expected).

Fields of papers citing papers by Tomokazu Kimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomokazu Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomokazu Kimura. The network helps show where Tomokazu Kimura may publish in the future.

Co-authorship network of co-authors of Tomokazu Kimura

This figure shows the co-authorship network connecting the top 25 collaborators of Tomokazu Kimura. A scholar is included among the top collaborators of Tomokazu Kimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomokazu Kimura. Tomokazu Kimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagumo, Yoshiyuki, Tomokazu Kimura, Yuta Sekino, et al.. (2025). Combined Molecular Subclass and Immune Phenotype Correlate to Atezolizumab Plus Radiation Therapy Response in Invasive Bladder Cancer: BPT-ART Phase 2 Study. International Journal of Radiation Oncology*Biology*Physics. 122(1). 168–180.
2.
Kandori, Shuya, Shuhei Suzuki, Kazuki Hamada, et al.. (2024). Adult genitourinary sarcoma: analysis using hospital-based cancer registry data in Japan. BMC Cancer. 24(1). 215–215. 2 indexed citations
3.
Shiga, Masanobu, Shuya Kandori, Yoshiyuki Nagumo, et al.. (2023). Complete Response to Enfortumab Vedotin in a Hemodialysis Patient with Metastatic Urothelial Carcinoma: A Case Report. SHILAP Revista de lepidopterología. 16(1). 429–433. 4 indexed citations
4.
Okubo, Reiko, Tomokazu Kimura, Koichi Asahi, et al.. (2022). Cost-effectiveness of mass screening for dipstick hematuria in Japan. Clinical and Experimental Nephrology. 26(5). 398–412. 7 indexed citations
5.
Sekino, Yuta, Hitoshi Ishikawa, Tomokazu Kimura, et al.. (2021). Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study. Contemporary Clinical Trials Communications. 21. 100724–100724. 6 indexed citations
6.
Kandori, Shuya, Masanobu Shiga, Yoshiyuki Nagumo, et al.. (2021). Case Report: Molecular Characterization of Aggressive Malignant Retroperitoneal Solitary Fibrous Tumor: A Case Study. Frontiers in Oncology. 11. 736969–736969. 9 indexed citations
7.
Kimura, Tomokazu, Koji Kawai, Shuya Kandori, et al.. (2020). Impact of centralization in primary retroperitoneal sarcoma treatment: analysis using hospital-based cancer registry data in Japan. International Journal of Clinical Oncology. 25(9). 1687–1694. 2 indexed citations
8.
Kawahara, Takashi, Takahiro Kojima, Shuya Kandori, et al.. (2019). TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer. PLoS ONE. 14(8). e0220173–e0220173. 4 indexed citations
9.
Yoshino, Takayuki, Jun Miyazaki, Takahiro Kojima, et al.. (2019). Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guérin induce antitumor immunity in a syngeneic murine bladder cancer model. PLoS ONE. 14(1). e0209196–e0209196. 10 indexed citations
10.
Miyazaki, Jun, Mizuki Onozawa, Satoshi Takahashi, et al.. (2019). The resonance® metallic ureteral stent in the treatment of malignant ureteral obstruction: a prospective observational study. BMC Urology. 19(1). 137–137. 18 indexed citations
11.
Takahashi, Shunji, Motohide Uemura, Tomokazu Kimura, et al.. (2019). A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma. Investigational New Drugs. 38(4). 1056–1066. 65 indexed citations
12.
Ikeda, Atsushi, Tomokazu Kimura, Mizuki Onozawa, et al.. (2014). Regional difference in cancer detection rate in prostate cancer screening by a local municipality in Japan. Prostate International. 2(1). 19–25.
13.
Uchida, Masahiro, Koji Kawai, Tomokazu Kimura, et al.. (2014). Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancer. International Journal of Clinical Oncology. 19(6). 1112–1117. 3 indexed citations
14.
Kawai, Koji, Tomokazu Kimura, Takahiro Kojima, et al.. (2014). Long-term outcomes of combined androgen blockade therapy in stage IV prostate cancer. Journal of Cancer Research and Clinical Oncology. 141(4). 759–765. 4 indexed citations
15.
Miyazaki, Jun, Tomokazu Kimura, Takahiro Kojima, et al.. (2014). Concurrent Urothelial Carcinoma in the Renal Pelvis of an Allograft Kidney and Native Recipient Bladder: Evidence of Donor Origin. Japanese Journal of Clinical Oncology. 44(4). 366–369. 13 indexed citations
16.
Takaoka, Eiichiro, Yoshiyuki Matsui, Takamitsu Inoue, et al.. (2013). Risk Factors for Intravesical Recurrence in Patients with High-grade T1 Bladder Cancer in the Second TUR Era. Japanese Journal of Clinical Oncology. 43(4). 404–409. 15 indexed citations
17.
Kondo, Yuko, Noriko Umegaki, Mika Terao, et al.. (2012). A Case of Generalized Acanthosis Nigricans with Positive Lupus Erythematosus-Related Autoantibodies and Antimicrosomal Antibody: Autoimmune Acanthosis Nigricans. Case Reports in Dermatology. 4(1). 85–91. 9 indexed citations
18.
Onozawa, Mizuki, Naoto Miyanaga, Shiro Hinotsu, et al.. (2012). Analysis of Intravesical Recurrence After Bladder-preserving Therapy for Muscle-invasive Bladder Cancer. Japanese Journal of Clinical Oncology. 42(9). 825–830. 11 indexed citations
19.
Miyagawa, Tomoaki, Satoru Ishikawa, Tomokazu Kimura, et al.. (2010). Real‐time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data. International Journal of Urology. 17(10). 855–860. 95 indexed citations
20.
Hegab, Ahmed E., Tohru Sakamoto, Yoshiaki Uchida, et al.. (2004). Association analysis of tissue inhibitor of metalloproteinase2 gene polymorphisms with COPD in Egyptians. Respiratory Medicine. 99(1). 107–110. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026